Problem to be solved

Neglected and high prevalence worldwide disease;

Major impact on public health;

Few options of treatment for disease;

Low efficacy of the drug used for the treatment of disease;

Hypersensitivity to anthelmintic compounds currently available

 
Proposed Innovation

Active ingredient for the preparation of anthelmintic pharmaceutical formulations, and reduced oviposition of S. mansoni, and other related species;

Application alone or associated, in liquid dosage forms, solid or semi-solid, sterile or not.
 

Differential

Possibility of human and veterinary formulation;

Substances obtained via a synthesis route, which uses a simple method and reliable results;

Process fast production and low cost.

 
Intellectual property status

BR 102013028927-2 A2
 

Tecnology transfer status

Partnership

 
Inventors

Geandra Batista Lima Nunes (UFPI)

José Maria Barbosa Filho (UFPB)

Luciana Muratori Costa (UFPI)

Celso Amorim Camara (UFRP)

George Laylson da Silva Oliveira (UFPI)

Rivelilson Mendes de Freitas (UFPI)

Stanley Juan Chavez Gutierrez (UFPI)

Josué de Moraes (UnG)

Pedro Luiz Silva Pinto (IAL)